Weight Loss Treatments Surge Among Kids: Are They Safe?
The rising use of GLP-1 therapies in children sparks concerns over long-term health effects.

The Surge in Weight Loss Medications
Weight loss medications like Ozempic and Wegovy have seen a significant rise in popularity. Many adults are turning to these new options instead of the traditional advice to eat less and exercise more. These medications offer an alternative for those who have struggled to lose weight through conventional methods. Their effectiveness and ease of use have made them a preferred choice for many seeking to shed pounds.
Celebrity Endorsements and Public Attention
Celebrities have played a role in boosting the popularity of medications like Ozempic and Wegovy. Public figures sharing their success stories have made these treatments more appealing to the general public. The term 'Ozempic face' has even become a common phrase, highlighting the widespread recognition of these medications. However, the high demand has also led to an increase in counterfeit and potentially harmful versions entering the market.
Growing Use Among Children and Teens
Beyond adults, these weight loss medications are becoming more popular among children and adolescents. With about one in five children in the U.S. facing obesity, the demand for effective treatments has surged. In 2023 alone, over 30,000 adolescents aged 12 to 17 used GLP-1 medications, according to a University of Michigan study. This trend reflects a growing awareness and willingness to address obesity early on.
Medical Experts Weigh In
Doctors emphasize the importance of early intervention in managing obesity to prevent future health issues. Pediatricians like Dr. Chris Straughn highlight that GLP-1 medications can be both effective and safe for young patients based on current research. However, they caution that long-term effects are not yet fully understood. It's important for medical professionals to continue studying these medications to ensure they remain a safe option for children and teens.
Safety and Long-Term Concerns
Despite their benefits, there are significant concerns about the long-term use of GLP-1 medications in children and adolescents. Experts like Dr. Dan Cooper point out that while these medications can help with weight loss, the impact on growing bodies and brains is not yet known. Puberty is a critical time for development, and there is worry that these medications might interfere with bone growth, muscle development, and brain changes. More research is needed to understand the potential long-term effects.
Conclusion: Balancing Benefits and Risks
Weight loss medications like Ozempic and Wegovy offer promising alternatives for managing obesity in both adults and young people. While they provide an effective solution for many, it is essential to approach their use with caution, especially in children and adolescents. Parents and healthcare providers must work together to ensure that these medications are used appropriately, balancing the immediate benefits with potential long-term risks. Encouraging healthy eating and active lifestyles remains crucial alongside any medical treatment.